Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved sexual function during recombinant human erythropoietin therapy.

J Bommer1, M Kugel, B Schwöbel

  • 1Department of Internal Medicine, University of Heidelberg, FRG.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|January 1, 1990
PubMed
Summary

Recombinant human erythropoietin (rHuEpo) therapy improved sexual function and well-being in male hemodialysis patients. However, this therapy did not significantly alter key sex hormone levels in the study group.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serological investigation of the prevalence of anti-dengue IgM and IgG antibodies in Attapeu Province, South Laos.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2004
Same author

Madelung deformity: clinical features, therapy and results.

Journal of pediatric orthopedics. Part B·2001
Same author

A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.

Journal of medicinal chemistry·2001
Same author

De novo glomerulonephritis in patients during remission from Wegener's granulomatosis.

Clinical nephrology·1992
Same author

Reduced capillary density in the myocardium of uremic rats--a stereological study.

Kidney international·1992
Same author

Renal histology in polycystic kidney disease with incipient and advanced renal failure.

Kidney international·1992

Area of Science:

  • Nephrology
  • Endocrinology
  • Sexual Medicine

Background:

  • Chronic kidney disease (CKD) significantly impacts patients' quality of life, including sexual function.
  • Hemodialysis, a treatment for end-stage renal disease, is associated with hormonal imbalances and sexual dysfunction.
  • Recombinant human erythropoietin (rHuEpo) is used to treat anemia in hemodialysis patients, potentially affecting overall health and sexual well-being.

Purpose of the Study:

  • To investigate the effects of recombinant human erythropoietin (rHuEpo) therapy on sexual function in male hemodialysis patients.
  • To assess changes in sex hormone levels in response to rHuEpo treatment.
  • To evaluate the impact of rHuEpo on patients' overall well-being, including physical and mental health.

Main Methods:

Related Experiment Videos

  • A cohort of seven male hemodialysis patients with stable sexual partners were studied.
  • Sexual function and hormone levels were assessed before and after 3-10 months of rHuEpo therapy.
  • A self-administered questionnaire evaluated sexual function, including libido and erection; hormone levels (testosterone, estradiol, prolactin, LH, FSH) were measured.

    • Main Results:

    • Hematocrit levels significantly increased from 22.2% to 30.6% with rHuEpo therapy.
    • Four out of seven patients reported improvements in sexual function, encompassing libido and erection.
    • Patients also reported enhanced physical fitness and mental alertness; however, no significant changes in serum sex hormone levels were observed.

    Conclusions:

    • rHuEpo therapy can positively influence self-reported sexual function and overall well-being in male hemodialysis patients.
    • The observed improvements in sexual function may be independent of significant changes in key sex hormone levels.
    • Further research is warranted to elucidate the mechanisms behind improved sexual function during rHuEpo treatment in this population.